Models show how COVID-19 cuts a neighborhood path
US Might Not See Life Get "Back To Normal" Until 2022, Dr. Fauci Warns
Moderna on track to report late-stage Covid-19 vaccine data
UH and CWRU announce study of AstraZeneca’s COVID-19 vaccine candidate
Yearlong study of coronavirus in frontline workers underway
Global COVID-19 Cases Near 45 Million After Another Record Day: Live Updates
Coronavirus stimulus checks: Joe Biden has an emergency action plan as well
Why We Can’t See COVID as a Wicked Problem
Moderna Scores $1.1B From Covid-19 Vaccine Deposits; Shares Rise 3%
Remdesivir for COVID-19: FDA approved but still unproven
Stocks Struggle To Stabilize After Worst Rout Since June
Covid-19 roundup: Boehringer pulls a drug out of the pipeline for a PhII Covid-19 trial; Novavax delays PhIII trial in US, with PhII data coming Friday
Amgen's 3Q Top Line Gains 12% Fueled By Strong Drug Sales
Gilead Cuts 2020 Guidance As Remdesivir Sales Disappoint
Mastercard Dips 8% As 3Q Profit Disappoints; Street Sticks To Buy
Pfizer or Merck: Which Pharma Stock Has More Upside Potential?
Japan’s Shionogi readies Covid-19 vaccine for December trial, says CEO
Commentary: In the race for a COVID-19 vaccine, how do we balance risk and safety?
COVID stress syndrome: 5 ways the pandemic is affecting mental health
57 COVID Infections From One Flight; Airlines Lie
Flying Blind: Clueless About Risk, We're Speeding Toward Systemic Failure
These 3 Penny Stocks Could Rack up Triple-Digit Gains, Says Leerink
Most people mount a strong antibody response to SARS-CoV-2 that does not decline rapidly
Vaccine sales recover at GSK in Q3, but lockdown fears weigh on shares
ESG Risks And Opportunities In Credit Ratings
Sanofi, GSK to supply vaccine doses to WHO-backed alliance
Pfizer Enters Final Stretch of Late-Stage Covid-19 Vaccine Trial
Turning a coronavirus protein into a nanoparticle could be key for COVID-19 vaccine
Covid-19 roundup: Boehringer pulls a drug out of the pipeline for a PhII Covid-19 trial; Novavax delays PhIII trial in US, with PhII data coming Friday;
News briefing: SpringWorks, Jazz exchange $35M and PTSD drug; Dr. Reddy's says cyberattack was ransomware